Faculty

PHARMACEUTICAL CHEMISTRY

Dr. K. Nagarajan is a Professor and Principal in the Department of Pharmaceutical Chemistry, KIET School of Pharmacy, KIET Group of Institutions, Delhi-NCR, Ghaziabad and he is Dynamic, Multifaceted, Quick Learner and One of the Responsible Leader of the Department having 24.4 years of affluent Teaching, Research and Industrial experience. He has completed his Ph. D in Pharmacy from Jadavpur University, Kolkata in 2010; M. Pharm (Pharmaceutical Chemistry) from Birla Institute of Technology, Ranchi in 2001; B. Pharm from Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore affiliated to The Tamilnadu Dr. M. G. R. Medical University, Chennai in 1998. Selected for a Colonel Fairleigh S. Dickinson International Scholarship of U.S $ 5000 for the 2005-2006 academic year in recognition of candidate’s potential and past educational achievements. Selected as Fellow of Institution of Chemists (India) (F.I.C) as Honorary Life Fellowship since 2020. Served as Scientist in MCD-Drug Discovery Department, Torrent Research Centre, Gandhi Nagar for a short stint in 2001. Qualified GATE’99 with 93.33 percentile having All India Rank of 190. Published 182 research papers in Journal of Repute, out of which 82 Scopus and 33 SCI indexed which includes 38 National and 144 International Journals, presented 72 papers which includes 49 National and 23 International Conferences, authored 11 Books, 17 Book Chapters, holds 18 Indian Patents with 2 Granted, delivered 18 Guest lectures, organized 16 events, completed 2 Expert trainer program & 18 MOOCs courses, participated in 17 continuous education learning programs, so far. Received 4 Grants with a cumulative worth of 38.00647 Lacs from Funding Bodies such as AICTE & AKTU. He is Life member of Various Professional Bodies like American Chemical Society, APTI, IPA, ISTE, SOPI, CSI, IFERP, The Indian Pharmacists Association. Awarded with CV Raman Award consecutively for the session 2017-18, 2018-19 and 2019-20 as Best Researcher by KIET Group of Institutions. Received KIET’s Best Faculty Incentive in session 2016-17 and 2012-13 for outstanding faculty for the superior performance in Academics and Research. Guided 2 Ph.D / Guiding 8 PhD, 59 PG and 38 UG student’s projects (107 students of UG/PG/PhD) so far. Active core team member in various inspection bodies such as PCI and CPCSEA. Serving as a Ph.D Panel Expert for Jamia Hamdard, New Delhi, DIPSAR, New Delhi, The Tamilnadu Dr MGR Medical University, Chennai and SRM University, Ghaziabad. He has more passion towards teaching core subjects like Biochemistry, Medicinal Chemistry, Computer aided drug design, Modern Pharmaceutical Analytical Techniques and Principles of Drug Discovery. He has a notable contribution to society during emergency situation by dispensing medicines during National Disaster Tsunami in December 2004 for the suffered victims in coastal areas of Vilundamavadi Panchayat of Nagapattinam district of Tamil Nadu during the tenure of work in Periyar College of Pharmaceutical Sciences for Girls, Trichy, Tamil Nadu. Dr. K. Nagarajan has been conferred with Best Teacher Award, 2022 in the “Overall Performance Category” on the auspicious occasion of Teacher’s day on September 5, 2022 by Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh at Visvesvaraya Hall, AKTU, Lucknow. Recently, Dr. K. Nagarajan has been conferred with Best Ph.D Supervisor Award, 2023 on the auspicious occasion of Teacher’s day on September 5, 2023 at KIET Group of Institutions, Ghaziabad. Nominated as a National Expert for recruitment of Technical Position interviews for Indian Pharmacopeial Commission, Ghaziabad as on 15th August, 2025. Invited for Empanelment as Assessor for PCI-NABET Ranking and Rating as on 18th August, 2025. He is holding regular membership of “American Chemical Society”, USA as on 24th January 2022 (Membership No: 32981071)

                  

• Dr. K. Nagarajan (2019-20 ). Recent updates on Antiviral drug design against COVID-19 using suitable enzyme targets. International Journal of Pharmaceutical Sciences Review and Research. ISSN:0976-044X
• Dr. K. Nagarajan (2019-20). An Insight for Potent In-Vitro Antioxidant Status of Short-Chain Peptides. International Journal of Peptide Research and Therapeutics. ISSN:1573-3149
• Kandasamy Nagarajan (2017-18). Antimicrobial Peptidomimetics for Recurrent Septicemia Infections: In Vitro Study for Immuno Compromised Disease Target. Drug Research. ISSN:0019462X
• Kandasamy Nagarajan (2016-17). Adverse drug reaction monitoring during antimicrobial therapy for septicemia patients at a University Hospital in New Delhi. Korean Journal of Internal Medicine. ISSN:1226-3303 
• K.Nagarajan, Parul Grover, Roma Ghai (2016-17). Anti-nociceptive effect of some synthesized smaller chain tripeptides and tetrapeptides in mice. Medicinal Chemistry Research. ISSN:1054-2523
• Kandasamy Nagarajan (2015-16). Lycopene potentiates the protective effect of Aliskiren on Doxorubicin- induced cardiomyopathy in rats. Journal of Pharmacy and Nutrition Sciences . ISSN:19275951
• K. Nagarajan (2022-23). Design of small chain peptides as inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase. Pharmacologyonline. ISSN:1827-8620
• K. Nagarajan (2022-23). Evaluation of Invitro antioxidant potency of Arnebia nobilis root extract. Pharmacologyonline. ISSN:1827-8620
• K. Nagarajan (2022-23). Analytical method development and validation parameters of drug Ivermectin. International Journal of Life Science and Pharma Research. ISSN:2250-0480
• K.Nagarajan (2022-23). Insilco screening and synthesis of tripeptides for tuberculosis. Europian Chemical Bulletin. ISSN:20635346
• K. Nagarajan, Snigdha Bhardwaj (2025). Docking and AI Based Classification cum Recurrent Neural Network Validation for predicting Antitubercular Leads against DPRE1 Enzyme target. Current Proteomics. ISSN:1875-6247
• Kandasamy Nagarjan, Lalit Mohan Nainwal, Snigdha Bhardwaj (2025). Analytical techniques for the quantification and validation of Resveratrol: A review. Anti-inflammatory and Anti-allergy agents in Medicinal Chemistry. ISSN:1871-5230
• Kandasamy Nagarajan (2025). Comparative evaluation of free available chlorine in Sodium hypochlorite solutions admixed with novel chelating agents. Endodontology. ISSN:0970-7212
• Kandasamy Nagarjan, Snigdha Bhardwaj, Surbhi Kamboj (2025). Method Development and Validation of Orlistat by Using RP-HPLC. Current Pharmaceutical Analysis. ISSN:1875-676X
• K. Nagarjan, Parul Grover, Richa Goel (2024). Method development and validation of Quetiapine fumarate by using RP-HPLC. Oriental Journal of Chemistry. ISSN:0970-920X
• Kandasamy Nagarajan, Snigdha Bhardwaj (2025). Analytical method development and validation of Efavirenz by using RP-HPLC. International Journal of Pharmaceutical Investigation. ISSN:2230-973X
• Pankaj Bhatt, K. Nagarajan, Shardendu Kumar Mishra, Praveen Kumar Dixit, Vinay Kumar, Sanjeev Kumar (2023). Artificial Intelligence in Pharmaceutical Industry: Revolutionizing Drug Development and Delivery. The Chinese Journal of Artificial Intelligence. ISSN:2666-7835
• Roma Ghai, K. Nagarajan, Parul Grover, Vinay Kumar, Richa Goel (2023). Bioassay guided Hepatoprotective activity of Polygonatum cirrhifolium against Isoniazid and Rifampicin induced hepatotoxicity in rats. Indian Drugs. ISSN:0019-462X
• K. Nagarjan, Parul Grover, Abhay Bhardwaj (2024). Development and Validation of Fast and Sensitive RP-HPLC Stability indicating method for Quantification of Teneligliptin in Bulk drug. Journal of Chromatographic Science. ISSN:1. 1945-239X
• K. Nagarajan, Roma Ghai, Parul Grover (2022). Identification of potent Bioassay guided terpenoid and glycoside root fractions of Astragalus candolleanus against clinically significant bacterial strains. International Journal of Microbiology. ISSN:1687-918X
• K. Nagarajan, Richa Goel, Praveen K. Dixit, Vidhu Saxena, Sanjeev Chauhan, Vinay Kumar (2022). Analytical method development and validation parameters of drug Ivermectin. International Journal of Life Science and Pharma Research. ISSN:2250-0480

• K. NAGARAJAN. Drug designing of peptidomimetics as antitubercular agent for the invitro predictive binding to P-gl. International Conference on Drug Design 2017. ISBN:NA
• K. NAGARAJAN. Invitro cardioprotective antioxidant activity of Peptides with the prediction of IC50 values. International Conference on Frontiers in Science & Technology(ICFST-17). ISBN:
• K. NAGARAJAN. Invitro antioxidant activity of Synthesized Peptidomimetics using the calculation of IC50 values. International Conference on Frontiers in Science & Technology(ICFST-17). ISBN:
• K. NAGARAJAN. Invitro antioxidant activity of the smaller chain peptides against DHODase enzyme target of Malaria. International Conference on Frontiers in Science & Technology(ICFST-17). ISBN:
• K. NAGARAJAN. Lipinski drug filters and Molinspiration for the shorter chain peptides: Identification of potent he. International Conference on Frontiers in Science & Technology(ICFST-17. ISBN:
• K. NAGARAJAN. Antioxidant activity of designed peptidomimetics based on fullerene-C60 scaffold shorter chain dipep. IHPA HEALTHCON 51st Annual Conference. ISBN:
• K. NAGARAJAN. Boman index, Drug like filters and Molecular dynamics as a tool in rational drug design: Application. Recent Advances in Computational Drug design. ISBN:

• K. NAGARAJAN (2014-11-30). Glycopeptides and their medicinal potency as antioxidants. Scholars Press. ISBN:978-3-659-84305-1
• K. NAGARAJAN (2014-05-31). Glutamic acid as antineoplastic agent-A Synthetic and Biological approach. Lambert Academic Publishing. ISBN:978-3-659-64012-4
• K. NAGARAJAN (2011-05-31). Basic Principles of Radioassays. Lambert Academic Publishing. ISBN:9783660000000
• K. NAGARAJAN (2019-01-07). Trends in Hyphenated Analytical Techniques. Lambert Academic Publishing. ISBN:9783840000000
• K. NAGARAJAN (2017-07-01). Fundamental Principles of Drug Discovery. Lambert Academic Publishers. ISBN:978-613-9-98144-1

• Dr. K. Nagarajan, Ms. Parul Grover, Ms. Mayuri Mishra, Dr. Vinay Kumar (2017-08-18). Design, Synthesis & Aminoacid Composition of Fullerene Based Peptidomimetics Against Leukemia And Ovarian Cancer. Indian Patent Office. Application Number:201611004953 A
• Dr. K. Nagarajan, Dr. Parul Grover, Dr. Roma Ghai, Ms. Garima Varshney (2019-06-14). Novel Peptidomimetics Lead as Potent Hepatoprotective Agent. Indian Patent Office. Application Number:201911021626 A
• Dr. Ashu Mittal, Dr. Alankar  Srivastava, Dr. K Nagarajan (2020-11-06). A HPLC -MS Method For Estimation Of Lopinavir And Ritonavir In Human Plasma Using Fluxetine  . Indian Patent Office. Application Number:202011045306 A
• KIET, Dr. Richa Goel, Dr. K. Nagarajan (1900-01-00). Refrigeration Unit with Independent Temperature Control Multiple Compartments space. Indian Patent Office. Application Number:360128-001
• Dr. Abhishek Kumar, Priya Bansal, Dr. N.G. Raghavendra Rao, Dr. Kandasamy Nagarajan, Piyush Mishra, Bharti Bhatiya, Prateek Tiwari, Irfan Ali (2023-01-06). METHOD FOR DEVELOPING SKIN CARCINOMA TO SCREEN AN ANTICANCER DRUG. Indian Patent Office. Application Number:202211056238 A
• Dr. K. Nagarajan, Ms. Vidhu Saxena (2022-02-25). Secure Decentralized Healthcare system for India. Indian Patent Office. Application Number:202211008326
• Dr. Abhay Bhardwaj, Mr. Anuj Pathak, Dr. K Nagarajan (1900-01-00). A ROOM ENVIRONMENTAL CONDITION MONITORING DEVICE. Indian Patent Office. Application Number:370996-001
• Dr. K. Nagarajan, Dr. Vibhav Kumar Sachan, Dr.Parul Grover, Dr.Roma Ghai, Dr.Garima Kapoor, Ms.Richa Goel, Ms.Ranjana Ranjan (2020-06-26). Antithrombotic And Antihypertensive Peptides. Indian Patent Office. Application Number:202011020473 A
• Binkey Srivastava, Kandasamy Nagarajan, Garima Kapoor, Richa Goel, Snigdha Bhardwaj, Parul Grover (2024-08-02). Synthesis of Smaller chain peptide candidates against M. Tuberculosis and mitigating lung injury associated with methotrexate treatment. Indian Patent Office . Application Number:202411054973 A
• K. Nagarajan, Richa Goel, Vidhu Saxena, Snigdha Bhardwaj, Garima Kapoor (2025-04-04). Peptide Therapeutics for Managing Neonatal Acute Lung Injury. Indian Patent Office . Application Number:202511027461 A
• K. Nagarjan, Richa Goel, Snigdha Bhardwaj, Sheena Mehta, Vidhu Saxena (2025-06-13). TLR-9 receptor in Tryptophan and Arginine peptide-mediated immunomodulation for tuberculosis therapy. Indian Patent Office . Application Number:202511050369 A

• Sridhar University, Pilani (1) AKTU (2) Amity University, Noida(1) Bansathali Vidyapith(1)
• AKTU Lucknow(2), Amity University, Noida (1)

• Dr. K. Nagarajan (2019-20). Design & Development of fullerene based novel peptide scaffolds as potent antitubercular agents. All India Council for Technical Education (AICTE)-RPS. Amount:22.17
• Dr. K. Nagarajan (2012-13). Design and Development of novel peptidomimetics as potential anticancer agents’’. All India Council for Technical Education (AICTE)-RPS. Amount:11.0 lakhs
• Dr. K. Nagarajan (2019-20). Impact of Artificial Intelligence in healthcare. AKTU, Lucknow. Amount:1 Lakh
• Dr. K. Nagarajan (2020-21). Development, Characterization and Evaluation of Topical Nanogel for Psoriasis. AKTU- VRPS. Amount:5 lakhs
• Dr. K. Nagarajan, Garima Kapoor, Richa Goel, Snigdha Bhardwaj (2024-25). Synthesis of Smaller chain peptide candidates against M. Tuberculosis and mitigating lung injury associated with methotrexate treatment. AICTE-KAPILA . Amount:5600

Email Id: k.nagarajan@kiet.edu

https://www.linkedin.com/in/k-nagarajan-90a99a136/